Fig. 1. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)
Fig. 2. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Fig. 3. Change of Transepidermal Water Loss (TEWL) between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)
Fig. 4. Change of Transepidermal Water Loss TEWL) between Treatment Group and Control Group in Baseline and 6 weeks Center between the medial aspect of the elbow and the wrist)
Table 1. Composition of PB301 lotion and Positive Control
Table 2. Schedule of Clinical Trial
Table 3. Distribution Chart of Participants
Table 4. Distribution of Sex, Antecedent Drug, Age, Height and Weight
Table 5. Change of Skin Hydration between Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 6. Change of Skin Hydration between Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 7. Change of Transepidermal Water Loss(TEWL) between Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 8. Change of Transepidermal Water Loss(TEWL) between Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 9. Change of Skin Hydration in Treatment Group between Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)
Table 10. Change of Skin Hydration in Treatment Group between Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)
Table 11. Change of Transepidermal Water Loss(TEWL) in Treatment Group between Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)
Table 12. Change of Transepidermal Water Loss(TEWL) in Treatment Group between Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)
Table 13. Change of Skin Hydration in Treatment Group between 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 14. Change of Skin Hydration in Treatment Group between 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 15. Change of Transepidermal Water Loss(TEWL) in Treatment Group between 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 16. Change of Transepidermal Water Loss(TEWL) in Treatment Group between 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 17. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 18. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 19. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 20. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 21. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)
Table 22. Change of Skin Hydration between Treatment Group and Control Group in Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)
Table 23. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 3 weeks(1㎝ below the medial aspect of the elbow)
Table 24. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline and 3 weeks(Center between the medial aspect of the elbow and the wrist)
Table 25. Change of Skin Hydration between Treatment Group and Control Group in 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 28. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 29. Change of Skin Hydration between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 26. Change of Skin Hydration between Treatment Group and Control Group in 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 27. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 30. Change of Skin Hydration between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 31. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(1㎝ below the medial aspect of the elbow)
Table 32. Change of Transepidermal Water Loss(TEWL) between Treatment Group and Control Group in Baseline, 3 weeks and 6 weeks(Center between the medial aspect of the elbow and the wrist)
Table 33. Adverse Events
Table 34. Change of EASI Score
Table 35. Change of itching Symptoms
Table 36. Change of the Frequency of Itching Symptoms
Table 37. Change of the Duration of itching Symptoms
Table 38. Change of Systolic Blood Pressure
Table 39. Change of Diastolic Blood Pressure
Table 40. Change of Pulse
Table 41. Change of Body Temperature
References
- Kim HJ. Refractory Atopic Dermatitis. 2016 KAAACI Annual Spring Congress: New Paradigms in Allergic Diseases. 2016:255-62.
- Hatakka K, Piirainen L, Pohjavuori S, Poussa T, Savilahti E, Korpela R. Allergy in day care children: prevalence and environmental risk factors. Acta Paediatr. 2009;98(5):817-22. https://doi.org/10.1111/j.1651-2227.2008.01198.x
- De Bruin Weller MS, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Evaluation of the child with atopic dermatitis. Clin Exp Allergy. 2012;42(3):352-62. https://doi.org/10.1111/j.1365-2222.2011.03899.x
- Maheswaran D, Zeng Y, Chan-Yeung M, Scott J, Osornio-Vargas A, Becker AB, et al. Exposure to Beta-(1,3)-D-glucan in house dust at age 7-10 is associated with airway hyperresponsiveness and atopic asthma by age 11-14. PLoS One. 2014;9(6):1-11.
- Ahn SK, Jang KH, Kim TH, Jeong J, Cheon SH, Kang YC, et al. Common Skin Disease. 3rd ed. Seoul:Jeong Woo Medical Book. 2015:75-111.
- Kang MS, Kim JB, Kim HT. A Clinical Study for the Effect of External Applications Containing Herbal Extracts on Mild Atopic Dermatitis Patients. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(3):40-55. https://doi.org/10.6114/jkood.2014.27.3.040
- Kang MS, Kim YM, Kim HT. A Clinical Study for Moisturizing Effects of Herbal Cosmetics Containing Sinhyotakrisan Extracts. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(1):81-92. https://doi.org/10.6114/jkood.2016.29.1.081
- O MJ, Yoo YB, Lim SH, Kim HT. A Clinical study for the effect of ointment contained Takrisodok-Eum on recovering the damaged skin barrier by Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2011;24(3):84-107. https://doi.org/10.6114/JKOOD.2011.24.3.084
- Lee JW, Go GY, Jung CH, You SJ, Kim YH, Ahn TW. Effect of DOGO phreatic weter containing germanium on Atopic Dermatitis in NC/Nga mouse. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(4):141-57. https://doi.org/10.6114/jkood.2014.27.4.141
- Son KJ, Park JH, Kim YH, Go GY, Kim YJ, Han JY, et al. Anti-atopic Effect of Chamaecyparis Obtusa oil (CHO_O) in DNCB-induced atopic dermatitis-like skin lesions NC/Nga mice. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(1):33-46. https://doi.org/10.6114/JKOOD.2016.29.1.033
- Kim JC, Hong SU. The Effects of Ionized Maifanite on Skin Damages of Nc/Nga Mice after Atopic Dermatitis Elicitation. J Korean Med Ophthalmol Otolaryngol Dermatol. 2007;30(1):29-42. https://doi.org/10.6114/JKOOD.2017.30.1.029
- Jung HJ, Hwang-Bo M, Do EJ, Suk JM, Kim MR, Kim YH, et al. A Clinical Research about Herbal Cosmetics Containing Phellinus linteus Extracts in Atopic Dermatitis Patients. J Korean Med Ophthalmol Otolaryngol Dermatol. 2010;23(3):154-64.
- Hwang SY, Jo MJ, Kim SC, Jee SY. Anti-inflammatory effects of the MeOH extract of Humulus japonicus in vivo. J Korean Med Ophthalmol Otolaryngol Dermatol. 2009;22(2):92-103.
- Sin MK. Clinical Traditional Herbalogy. Seoul:Younglimsa. 1997:449-50.
- Hur JY, Jeong CH, Shim KH. Chemical Components of Humulus japonicus Leaves and Stalks. J. Agriculture & Life Sciences. 2003;37(1):1-7.
- Lim DB, Lee YJ. The Effect of Humulus japonicus on Analgesia, Anti-inflammation, and Urination. J. of Herbology. 1993;8(1):69-75.
- Lee HS. Preventive effect and mechanism of Humulus japonicus extract on obesity. Major in Pharmacology. The Graduate School of Chung-Ang University. 2017.
- Hong SM. Beneficial effect of Humulus japonicus extract on hyperlipidemia and fatty liver induced by high fat diet obesity. Major in Pharmacology, Department of Medicine. The Graduate school of Chung-Ang University. 2014.
- Hwang SY. Anti-inflammaory effects of the MeOH extract of Humulus japonicus in vivo and in vitro. Department of Oriental Medicine. Graduate school of Daegu Haany University, Daegu, Korea. 2008.
-
Park SW, Chung SK, Park JC. Active Oxygen Scavenging Activity of Luteolin-7-O-
${\beta}$ -D-Glucoside Isolated from Humulus japonicus. J. Korean. Soc. Food. Sci, Nutr. 2000;29(1):106-10. - Lee SH. The Protective Effect of Humulus japonicus Extracts on Ethanol-Induced Chronic Hepatotoxicity in Rats. Major in Health, Social & Clinical Pharmacy Dept. of Pharmacology. The Graduate school Chung-Ang University. 2017.
- Moon SH. Studies of the effects of Humuli Herba on rats with nephritis induced by LPS. Dept. of Oriental medicine. Graduate School of Kyungwon University. 2008.
- Lee JH, Lee KC, Ha DH, Son IH, Lee WB, Oh YK, et al. Effect of Herba Humuli on the Cardiotoxicity Mediated by Methotrexate in Clutured Myocardial cells. Korean J. Oriental Medical Physiology & Pathology. 2001;15(4):585-9.
- KDA Textbook Editing Board. Textbook of Dermatology. 6th edition. Seoul:medbook. 2014:202-13.
- Gong NM, Jee SY. A Literature study about comparison of Eastern-Western medicine on the Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 1999;12(1):241-53.
- Heo J. A new Translation Donguibogam. Seoul:Bubin Publishers Co. 2005:769,3565.
- Do HK. Myeonguibyeolrok. Bejing: Inminwisaeng Publishing, Inc. 1986:165.
- Hwang SY, Jung HJ, Jang WS, Jo MJ, Kim SC, Jee SY. Anti-inflammatory effects of the MeOH extract of Humulus japonicus in vitro. J Korean Med Ophthalmol Otolaryngol Dermatol. 2009;22(3):71-9.
- Hong MS, Son ES, Lee SJ, Lee SK, Lee YJ, Song SD. Anti-mycobacterial Effects of the Extract of Humulus japonicus. Korean Journal of Food Science and Technology. 2014;46(1):94-9. https://doi.org/10.9721/KJFST.2014.46.1.94
- Lee YR, Kim KY, Lee SH, Kim MY, Park HJ, Jeong HS. Antioxidant and Antitumor Activities of Methanolic Extracts from Humulus japonicus. Korean Journal of Food and Nutririon. 2012;25(2):357-61. https://doi.org/10.9799/ksfan.2012.25.2.357